Skip to content

The effect of Inulin prebiotic supplementation (inulin or Oligofructose-enriched inulin) on type2 diabetic patients

The effect of Inulin prebiotic supplementation (inulin or Oligofructose-enriched inulin) on antioxdant status, metabolic, inflammatory and anti-inflammatory factors in type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110293253N4
Enrollment
66
Registered
2011-11-15
Start date
2011-11-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Endocrine, nutritional and metabolic diseases

Interventions

Intervention 1: Intervention group1: Inulin powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months. Intervention 2: Placebo group: dextrin m
Treatment - Other
Treatment - Drugs
Intervention group1: Inulin powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months
Intervention group2: Oligofructose-enriched inulin powder 10 g (2*5 gr)/d, divided into 2 portions of 5g each to be eaten during breakfast and dinner, for two months

Sponsors

Health and Nutrition Faculty, Tabriz University of Medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 30-65 years old, 25= BMI <35, having diabetes at least 6 months prior to the study, consumption of blood glucose lowering drug,. typical ?ber intake <25 g ?ber/d and inulin fructans intake =200 g ?ber/d. Exclusion criteria: consumption of antioxidants supplements during last 3 months prior to the study, using insulin, pregnancy, lactation, acute renal disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Dietary intake. Timepoint: 8 weeks. Method of measurement: 24 hours-food recal questionnaire.;Serum antioxidant status. Timepoint: 8 weeks. Method of measurement: measurement of SOD,GPX-H,TAC,MDA.;Total grelin level. Timepoint: 8 weeks. Method of measurement: Serum level of fasting total grelin.;Lipid profiles. Timepoint: 8 weeks. Method of measurement: TC, TG, LDL, HDL.;Insulin level. Timepoint: 8 weeks. Method of measurement: Serum level of fasting insulin.;Blood glucose & HbA1c. Timepoint: 8 weeks. Method of measurement: fasting blood glucose & HbA1c.;Inflammatory factors. Timepoint: 8 weeks. Method of measurement: HS-CRP,TNF-a,IL-6,IFN-?.;Anti-Inflammatory factor. Timepoint: 8 weeks. Method of measurement: IL-10.

Secondary

MeasureTime frame
Anthropomethric indices. Timepoint: 8 weeks. Method of measurement: Weight, Height, BMI.WB,WHR.;Appetite. Timepoint: 8 weeks. Method of measurement: questionnaire.;Lipopolysaccharide. Timepoint: 8 weeks. Method of measurement: serum Lipopolysaccharide.;Blood pressure. Timepoint: 8 weeks. Method of measurement: blood pressure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvin Dehghan

Faculty of Health and Nutrition, Tabriz University Of Medical Sciences

dehghan.parvin@yahoo.com+98 937 139 5660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026